This funding opportunity aims to address critical research needs in the development and acceptability of appropriate pediatric drug formulations across various age groups. It strongly encourages the creation of novel drug delivery systems specifically tailored for the pediatric population. Investigators are invited to propose new approaches, concepts, and superior techniques for pediatric formulation development and testing, moving beyond currently used methodologies. This grant supports discrete, well-defined projects that can be realistically completed within a two-year timeframe, requiring limited financial resources. The ultimate goal of this initiative is to advance innovative and effective solutions for administering medications to children safely and acceptably.
Opportunity ID: 292828
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-17-191 |
| Funding Opportunity Title: | Development of Appropriate Pediatric Formulations and Pediatric Drug Delivery Systems (R03) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health Income Security and Social Services |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.865 — Child Health and Human Development Extramural Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Mar 29, 2017 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | May 07, 2020 |
| Current Closing Date for Applications: | May 07, 2020 |
| Archive Date: | Jun 12, 2020 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $50,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | County governments Private institutions of higher education For profit organizations other than small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) Special district governments Public and State controlled institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal governments (Federally recognized) Small businesses Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) State governments City or township governments |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this funding opportunity announcement (FOA) is to address different and complementary research needs for the development and acceptability of pediatric drug formulations in different age groups. This FOA also encourages the development of novel drug delivery systems in the pediatric population. Investigators are encouraged to explore approaches and concepts new to the area of pediatric formulation development and testing and use newly developed techniques superior to the ones currently used in the field. This FOA supports discrete, well-defined projects that realistically can be completed in two years and that require limited levels of funding. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-17-191.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-D | Use for due dates on or before January 24, 2018 | PKG00231711 | May 16, 2017 | Jan 24, 2018 | View | |
| FORMS-E | Use for due dates on or before May 24, 2020 | PKG00236252 | Nov 15, 2017 | May 24, 2020 | View | |
| FORMS-F | Use for due dates on or after May 25, 2020 | PKG00259669 | May 16, 2017 | May 07, 2020 | View |
Package 1
Mandatory forms
292828 RR_SF424_2_0-2.0.pdf
292828 PHS398_CoverPageSupplement_3_0-3.0.pdf
292828 RR_OtherProjectInfo_1_3-1.3.pdf
292828 PerformanceSite_2_0-2.0.pdf
292828 RR_KeyPersonExpanded_2_0-2.0.pdf
292828 PHS398_ResearchPlan_3_0-3.0.pdf
Optional forms
292828 RR_Budget_1_3-1.3.pdf
292828 RR_SubawardBudget30_1_3-1.3.pdf
292828 PHS398_ModularBudget_1_2-1.2.pdf
292828 PHS_Inclusion_Enrollment_Report-1.0.pdf
292828 PHS_AssignmentRequestForm-1.0.pdf
Package 2
Mandatory forms
292828 RR_SF424_2_0-2.0.pdf
292828 PHS398_CoverPageSupplement_4_0-4.0.pdf
292828 RR_OtherProjectInfo_1_4-1.4.pdf
292828 PerformanceSite_2_0-2.0.pdf
292828 RR_KeyPersonExpanded_2_0-2.0.pdf
292828 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
292828 RR_Budget_1_4-1.4.pdf
292828 RR_SubawardBudget30_1_4-1.4.pdf
292828 PHS398_ModularBudget_1_2-1.2.pdf
292828 PHS_AssignmentRequestForm_2_0-2.0.pdf
Package 3
Mandatory forms
292828 RR_SF424_2_0-2.0.pdf
292828 PHS398_CoverPageSupplement_5_0-5.0.pdf
292828 RR_OtherProjectInfo_1_4-1.4.pdf
292828 PerformanceSite_2_0-2.0.pdf
292828 RR_KeyPersonExpanded_2_0-2.0.pdf
292828 PHS398_ResearchPlan_4_0-4.0.pdf
292828 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
292828 RR_Budget_1_4-1.4.pdf
292828 RR_SubawardBudget30_1_4-1.4.pdf
292828 PHS398_ModularBudget_1_2-1.2.pdf
292828 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
